BMC (BioMed Central)

Cancer Nanotechnology Template

Write in a clean editor, then format for Cancer Nanotechnology in one click — DocuGuru applies the official BMC (BioMed Central) template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.

About the Cancer Nanotechnology format

Cancer Nanotechnology is a peer-reviewed journal published by BMC (BioMed Central), covering Nanoparticle-Based Drug Delivery, Nanoplatforms for cancer theranostics, RNA Interference and Gene Delivery. Over its lifetime it has published 454 papers, which have received 10,368 citations.

PublisherBMC (BioMed Central)
Reference styleNumbered (Vancouver)
Numbered — [1], [2] in the text
1. Smith A, Jones B, Lee C. A representative article title. Cancer Nanotechnology. 2023;12(3):45–58.

Formats any DOI in Cancer Nanotechnology style. No sign-up.

Publishes research inNanoparticle-Based Drug Delivery Nanoplatforms for cancer theranostics RNA Interference and Gene Delivery Graphene and Nanomaterials Applications Advanced biosensing and bioanalysis techniques
ISSN1868-6958
Citation impact (2-yr)6.56
h-index50
i10-index246
Article processing charge$1,582
Open accessYes — indexed in DOAJ
Top institutions publishing hereTabriz University of Medical Sciences
Journal websitelink.springer.com
You getA submission-ready PDF and the editable LaTeX source — ready to submit.

Papers published in Cancer Nanotechnology per year

9
2014
4
2015
11
2016
10
2017
11
2018
11
2019
15
2020
34
2021
56
2022
85
2023
62
2024
57
2025

Citation impact of Cancer Nanotechnology by publication year

523
2014
116
2015
783
2016
749
2017
598
2018
751
2019
463
2020
1K
2021
718
2022
1.3K
2023
733
2024
267
2025

Citations each year’s papers have accumulated so far — the most recent years are still building up.

Most-cited papers in Cancer Nanotechnology

Nanomedicine review: clinical developments in liposomal applications

Esteban Beltrán-Gracia, Adolfo López-Camacho, Inocencio Higuera‐Ciapara et al. · 1 Dec 2019

Abstract Background In recent years, disease treatment has evolved strategies that require increase in pharmaceutical agent’s efficacy and selectivity while decreasing their toxicity in normal tissues. These requirements have led to the development of nanoscale liposome systems for drug release. This review focuses on lipid features, pharmacological properties of liposomal formulations and the clinical studies…

Gold nanoparticles for cancer radiotherapy: a review

Kaspar Haume, Soraia Rosa, Sophie Grellet et al. · 3 Nov 2016

Radiotherapy is currently used in around 50% of cancer treatments and relies on the deposition of energy directly into tumour tissue. Although it is generally effective, some of the deposited energy can adversely affect healthy tissue outside the tumour volume, especially in the case of photon radiation (gamma and X-rays). Improved radiotherapy outcomes can be…

Biological mechanisms of gold nanoparticle radiosensitization

Soraia Rosa, Chris Connolly, Giuseppe Schettino et al. · 1 Feb 2017

There has been growing interest in the use of nanomaterials for a range of biomedical applications over the last number of years. In particular, gold nanoparticles (GNPs) possess a number of unique properties that make them ideal candidates as radiosensitizers on the basis of their strong photoelectric absorption coefficient and ease of synthesis. However, despite…

Antiangiogenic and antiapoptotic effects of green-synthesized zinc oxide nanoparticles using Sargassum muticum algae extraction

Zahra Sanaeimehr, Iraj Javadi, Farideh Namvar · 22 Mar 2018

BACKGROUND: Algae are one of the natural materials used to green synthesis of nanoparticles. This method leads to minimize the toxicity of the chemical materials used to nanoparticle synthesis. METHODS: algae extraction used to evaluate its cytotoxicity and apoptotic properties on human liver cancer cell line (HepG2). RESULTS: Trypan blue assay results demonstrate a concentration-dependent…

Green synthesis of gold nanoparticles and their anticancer activity

Ravi Geetha, T. Ashokkumar, T. Selvaraj et al. · 4 Jun 2013

Abstract As the nano revolution unfolds, it is imperative to integrate nanoscience and medicine. The secret gleaned from nature have led to the generation of biogenic technologies for the fabrication of advanced nanomaterials. Present investigation discloses the gold nanoparticles biosynthesizing capability of the flower of pharmacologically important tree Couroupita guianensis . Rapid, cost-effective, one-step process…

Cancer Nanotechnology template — frequently asked questions

How do I write a paper in the Cancer Nanotechnology format?
In DocuGuru you write your manuscript in a normal editor — no LaTeX setup required — and select the Cancer Nanotechnology template. When you export, DocuGuru compiles the paper into the official BMC (BioMed Central) format and hands you a submission-ready PDF along with the editable LaTeX source.
What reference style does Cancer Nanotechnology use?
Cancer Nanotechnology uses Numbered (Vancouver) references, shown as numbered [1], [2] markers in the text. DocuGuru formats every in-text citation and the reference list in this exact style automatically. A reference appears like this: 1. Smith A, Jones B, Lee C. A representative article title. Cancer Nanotechnology. 2023;12(3):45–58.
Do I need to know LaTeX to submit to Cancer Nanotechnology?
No. DocuGuru generates the bmcart LaTeX class and compiles the PDF for you in the background, so you get a BMC (BioMed Central)-ready Cancer Nanotechnology document without writing any LaTeX. If you do want it, the LaTeX source is included in the export.
Can I import an existing draft into the Cancer Nanotechnology template?
Yes. Paste or upload your current manuscript — Word, LaTeX, Markdown, or plain text — and DocuGuru reflows it into the Cancer Nanotechnology format with correct headings, figures, tables, and numbered citations.
What is Cancer Nanotechnology?
BMC / BioMed Central journal. It is a life sciences and medicine journal, published by BMC (BioMed Central).
Can I export a submission-ready Cancer Nanotechnology PDF?
Yes — DocuGuru produces a PDF built with the official Cancer Nanotechnology template (the bmcart class) that is ready to submit to BMC (BioMed Central), together with the matching LaTeX source files.
How much does the Cancer Nanotechnology template cost?
You can start writing in the Cancer Nanotechnology template for free. Exporting the final submission-ready Cancer Nanotechnology PDF and LaTeX source is part of DocuGuru's paid plans — see the app for current pricing.
Use the Cancer Nanotechnology template